Merck naming troubles continue

Share this article:

Same-name problems continue to plague US-based and Germany-based Mercks. Bloomberg reports that while confusion has been an ongoing concern since the companies split in the early 20th century, a recent protest by the StopAIDS group is further proof that a different home base is not enough for activists to go on.

The latest problem is that activists protested the German Merck, known as Merck KGaA, in front of which they pitched a complaint against its move to block low-cost copies of patented drugs from flowing into South Africa, but the company that is actually involved is the Merck which has headquarters in New Jersey.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.